Evidence map›Paper›PMID 39924485›Full record

Observational studyBMC infectious diseases2025

Association between cytokine and increased risk of death in ART- naïve and ART-non-adherence patients hospitalized with advanced HIV disease.

Yury Oliveira Chaves, Wellington Mota Gama, Monique Freire Dos Reis, Bárbara José Antunes Baptista, Taynná Vernalha Rocha Almeida, Antônio Alcirley da Silva Balieiro, Allyson Guimarães da Costa, Hiochelson Najibe Dos Santos Ibiapina, Andrea Teixeira de Carvalho, Thaissy Dos Santos Xavier and 9 more

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yury Oliveira Chaves *Programa de Pós-graduação em Ciências da Saúde, Universidade Federal do Amazonas, Manaus, Amazonas, 69020-160, Brazil.
Wellington Mota Gama *Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas, Manaus, Amazonas, 69080-900, Brazil.
Monique Freire Dos ReisDepartamento de Patologia e Medicina Legal, Universidade Federal do Amazonas, Manaus, Amazonas, 69020-160, Brazil.
Bárbara José Antunes BaptistaPrograma de Pós-graduação em Ciências da Saúde, Universidade Federal do Amazonas, Manaus, Amazonas, 69020-160, Brazil.
Taynná Vernalha Rocha AlmeidaPrograma de Pós-graduação em Ciências da Saúde, Universidade Federal do Amazonas, Manaus, Amazonas, 69020-160, Brazil.
Antônio Alcirley da Silva BalieiroPrograma de Pós-Graduação em Biologia da Relação Patógeno-Hospedeiro, Fundação Oswaldo Cruz-Instituto Leônidas e Maria Deane, Manaus, Amazonas, 69057-070, Brazil.
Allyson Guimarães da CostaPrograma de Pós-graduação em Ciências Aplicadas à Hematologia, PPGH-UEA/HEMOAM, Manaus, Amazonas, 69050-001, Brazil.
Hiochelson Najibe Dos Santos IbiapinaPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Amazonas, 69040-000, Brazil.
Andrea Teixeira de CarvalhoLaboratório de Biomarcadores de Diagnóstico e Monitoração, Centro de Pesquisas René Rachou, Fundação Oswaldo - Fiocruz Minais Gerais, Belo Horizonte, Minas Gerais, 30190-002, Brazil.
Thaissy Dos Santos XavierLaboratório de Diagnóstico e Controle de Doenças Infecciosas na Amazônia (DCDIA), Instituto Leônidas e Maria Deane (ILMD)- Fiocruz Amazônia, Manaus, Amazonas, 69057-070, Brazil.
Marly Marques de MeloFundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas, 69057-070, Brazil.
Rebeca de Souza PinheiroLaboratório de Diagnóstico e Controle de Doenças Infecciosas na Amazônia (DCDIA), Instituto Leônidas e Maria Deane (ILMD)- Fiocruz Amazônia, Manaus, Amazonas, 69057-070, Brazil.
Jhennyffer Mendes de SouzaLaboratório de Biomarcadores de Diagnóstico e Monitoração, Centro de Pesquisas René Rachou, Fundação Oswaldo - Fiocruz Minais Gerais, Belo Horizonte, Minas Gerais, 30190-002, Brazil.
Zeca Manuel SalimoPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Amazonas, 69040-000, Brazil.
Olindo Assis Martins FilhoLaboratório de Biomarcadores de Diagnóstico e Monitoração, Centro de Pesquisas René Rachou, Fundação Oswaldo - Fiocruz Minais Gerais, Belo Horizonte, Minas Gerais, 30190-002, Brazil.
Marcus Vinícius Guimarães de LacerdaPrograma de Pós-Graduação em Biologia da Relação Patógeno-Hospedeiro, Fundação Oswaldo Cruz-Instituto Leônidas e Maria Deane, Manaus, Amazonas, 69057-070, Brazil.
Adele Schwartz BenzakenPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Amazonas, 69040-000, Brazil.
Luiz Carlos de Lima FerreiraPrograma de Pós-graduação em Ciências da Saúde, Universidade Federal do Amazonas, Manaus, Amazonas, 69020-160, Brazil.
Paulo Afonso NogueiraLaboratório de Diagnóstico e Controle de Doenças Infecciosas na Amazônia (DCDIA), Instituto Leônidas e Maria Deane (ILMD)- Fiocruz Amazônia, Manaus, Amazonas, 69057-070, Brazil. paulonogueirafiocruz@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite progress in healthcare for people living with HIV/AIDS (PLWHA), many still present with advanced HIV, thus increasing their risk of death. Late initiation of treatment and poor adherence to antiretroviral therapy (ART) are key contributing factors. This study aimed to evaluate cytokines as mortality predictors among hospitalized PLWHA. It assessed the risk of death between ART-naïve and ART-non-adherent PLWHA with advanced HIV and quantified immunological markers in post-mortem samples to determine the influence of irregular ART use.

methodsA longitudinal observational study was conducted at the Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD) in Manaus, Brazil, with 111 participants recruited between 2018 and 2019. Clinical and laboratory data were obtained from electronic medical records. Plasma samples were analyzed for 27 cytokines/chemokines using the Luminex

resultsART-naïve PLWHA had a higher risk of death. Most of the 27 immunological markers analyzed in the post-mortem were elevated in those who died compared to those who were discharged. Increased levels of IFNγ, CCL2, and CCL3 were associated with death. Elevated immunological markers in ART-naïve PLWHA correlated with CD4 cell counts. Notably, IL-17 increased in ART-naïve PLWHA, while IL-2 increased in ART-non-adherent PLWHA, indicating a dichotomy. T helper-2 responses were marked by IL-9 in ART-naïve and IL-5 in ART-non-adherent PLWHA.

conclusionsART-naïve PLWHA hospitalized with advanced HIV have a higher risk of death. Some immunological markers are possible predictors of death upon hospital admission due to HIV/AIDS, and their levels were found to be increased in post-mortem blood samples. Our findings suggest a polarized response among ART-naïve and ART-non-adherent PLWHA.

Indexed as

Anti-HIV AgentsCytokinesHIV InfectionsAdultBiomarkersBrazilFemaleHospitalizationHumansLongitudinal StudiesMaleMedication AdherenceMiddle AgedAnti-HIV AgentsBiomarkersCytokinesHIV/AIDSImmunological markersLate presentationMortality biomarkersOpportunistic infectionsTherapeutic failure

Identifiers

PMID39924485
PMCPMC11808995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.